Feature story
Breast Cancer Drug Shows Long-Lasting Prevention Power
THURSDAY, Dec. 12, 2019 (U.S. News & World Report)—Nearly six years after stopping a five-year regimen of the breast cancer drug anastrozole, women at high risk for breast cancer were 50% less likely to have been struck by the disease, new research shows.
The trial included more than 3,800 postmenopausal women at high risk for breast cancer. They were deemed to be at high risk for a variety of reasons, including having two or more blood relatives with breast cancer, having a mother or sister who developed breast cancer before age 50, and having a mother or sister who had breast cancer in both breasts.
In other news…
NBC’s Kristen Dahlgren shares the unusual breast cancer symptom she nearly missed
Dec. 11, Today
Even a Little Alcohol May Raise Cancer Risk
Dec. 9, The New York Times
Study links frozen embryo transfer to higher childhood cancer risk
Dec. 10, CNN
Senate Confirms Stephen Hahn to Head F.D.A.
Dec. 12, The New York Times
The Foundation in the News
Washington’s Top 100 Events 2019
TUESDAY, Dec. 10, 2019 (BizBash)—More than $1.5 million was raised at the 25th annual gala, held at the National Building Museum. Senator Bill Cassidy (Republican of Louisiana) and Senator Mazie Hirono (Democrat of Hawaii) were honored as cancer champions, and honorary Congressional co-chairs came from both parties. Next: May 14, 2020
No Comments